Salagen 5 mg Film Coated Tablets (Pilocarpine)-Revised SPC

Source: eMC (electronic Medicines Compendium)

Keywords: Salagen, Pilocarpine

Date published: 07/12/2011 16:42

Type of SPC Change: Revised SPC

Generic drug name: Pilocarpine

Drug brand name: Salagen

Legal status: POM

Pharmaceutical manufacturer: Novartis Pharmaceuticals UK Ltd

Summary
by: Atisha Sharma

There have been significant updates to several sections of the SPC, including the following:

 

Changes to section 4.9-Overdose

 

Overdose may lead to a 'cholinergic crisis' characterised by both muscarinic and nicotinic effects.

 

Signs of overdose due to muscarinic effects may include abdominal cramps, diarrhoea, nausea and vomiting, involuntary defecation and urination, sweating, salivation, increased bronchial secretions, miosis, bradycardia and hypotension.

Nicotinic effects may include involuntary twitching, fasciculations and generalised weakness.

 

Parenteral atropine may be used as an antidote to the muscarinic effects. Supportive treatment should be given as required; artificial respiration should be instituted if respiratory depression is severe.

 

Please refer to SPC link below for full information on all changes.

SPC

Preview your comment

Add new comment

Comment text:

Comments

There are no comments yet. You could be the first! You must be Logged In to comment.